During the past decade, Ephrata Cancer Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 42 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 29 clinical trials were completed. i.e. 90.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ephrata Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "NRG Oncology" with 7 trials sponsored and "NSABP Foundation Inc" with 7 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ephrata Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Ephrata Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IVA Lung Cancer AJCC v8" (7 trials) and "Stage IVB Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Ephrata Cancer Center" in a lesser frequency.

Most popular intervention types in "Ephrata Cancer Center" are "Drug" (90 trials), "Other" (71 trials), "Biological" (50 trials), "Procedure" (28 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (30 trials), "Questionnaire Administration" (17 trials), "Biospecimen Collection" (16 trials) and "Computed Tomography" (16 trials). Other intervention names were less common.

The vast majority of trials in "Ephrata Cancer Center" are 81 trials for "All" genders, 23 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Ephrata Cancer Center". undefined are not yet recruiting, 25 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Ephrata Cancer Center, 3 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Ephrata Cancer Center, 0 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".